These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 21840311)

  • 1. MEMO associated with an ErbB2 receptor phosphopeptide reveals a new phosphotyrosine motif.
    Feracci M; Pimentel C; Bornet O; Roche P; Salaun D; Badache A; Guerlesquin F
    FEBS Lett; 2011 Sep; 585(17):2688-92. PubMed ID: 21840311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Memo is homologous to nonheme iron dioxygenases and binds an ErbB2-derived phosphopeptide in its vestigial active site.
    Qiu C; Lienhard S; Hynes NE; Badache A; Leahy DJ
    J Biol Chem; 2008 Feb; 283(5):2734-40. PubMed ID: 18045866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Memo is a cofilin-interacting protein that influences PLCgamma1 and cofilin activities, and is essential for maintaining directionality during ErbB2-induced tumor-cell migration.
    Meira M; Masson R; Stagljar I; Lienhard S; Maurer F; Boulay A; Hynes NE
    J Cell Sci; 2009 Mar; 122(Pt 6):787-97. PubMed ID: 19223396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck.
    Eck MJ; Shoelson SE; Harrison SC
    Nature; 1993 Mar; 362(6415):87-91. PubMed ID: 7680435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissection of the energetic coupling across the Src SH2 domain-tyrosyl phosphopeptide interface.
    Lubman OY; Waksman G
    J Mol Biol; 2002 Feb; 316(2):291-304. PubMed ID: 11851339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships of small phosphopeptides, inhibitors of Grb2 SH2 domain, and their prodrugs.
    Liu WQ; Vidal M; Olszowy C; Million E; Lenoir C; Dhôtel H; Garbay C
    J Med Chem; 2004 Feb; 47(5):1223-33. PubMed ID: 14971902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual specificity of Src homology 2 domains for phosphotyrosine peptide ligands.
    Gay B; Furet P; García-Echeverría C; Rahuel J; Chène P; Fretz H; Schoepfer J; Caravatti G
    Biochemistry; 1997 May; 36(19):5712-8. PubMed ID: 9153411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure and ligand recognition of the phosphotyrosine binding domain of Shc.
    Zhou MM; Ravichandran KS; Olejniczak EF; Petros AM; Meadows RP; Sattler M; Harlan JE; Wade WS; Burakoff SJ; Fesik SW
    Nature; 1995 Dec; 378(6557):584-92. PubMed ID: 8524391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mediator of ERBB2-driven cell motility (MEMO) promotes extranuclear estrogen receptor signaling involving the growth factor receptors IGF1R and ERBB2.
    Jiang K; Yang Z; Cheng L; Wang S; Ning K; Zhou L; Lin J; Zhong H; Wang L; Li Y; Huang J; Zhang H; Ye Q
    J Biol Chem; 2013 Aug; 288(34):24590-9. PubMed ID: 23861392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of phosphotyrosine recognition by the SH2 domain of the Src kinase.
    Bradshaw JM; Mitaxov V; Waksman G
    J Mol Biol; 1999 Nov; 293(4):971-85. PubMed ID: 10543978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calorimetric examination of high-affinity Src SH2 domain-tyrosyl phosphopeptide binding: dissection of the phosphopeptide sequence specificity and coupling energetics.
    Bradshaw JM; Waksman G
    Biochemistry; 1999 Apr; 38(16):5147-54. PubMed ID: 10213620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of the cellular import of functionally active SH2-domain-interacting phosphopeptides.
    Kertész A; Váradi G; Tóth GK; Fajka-Boja R; Monostori E; Sármay G
    Cell Mol Life Sci; 2006 Nov; 63(22):2682-93. PubMed ID: 17075693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remote changes in the dynamics of the phosphotyrosine-binding domain of insulin receptor substrate-1 induced by phosphopeptide binding.
    Jarymowycz VA; Stone MJ
    Biochemistry; 2008 Dec; 47(50):13371-82. PubMed ID: 19053277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Memo mediates ErbB2-driven cell motility.
    Marone R; Hess D; Dankort D; Muller WJ; Hynes NE; Badache A
    Nat Cell Biol; 2004 Jun; 6(6):515-22. PubMed ID: 15156151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probing the "two-pronged plug two-holed socket" model for the mechanism of binding of the Src SH2 domain to phosphotyrosyl peptides: a thermodynamic study.
    Bradshaw JM; Grucza RA; Ladbury JE; Waksman G
    Biochemistry; 1998 Jun; 37(25):9083-90. PubMed ID: 9636054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phosphoproteomic analysis of the ErbB2 receptor tyrosine kinase signaling pathways.
    Mukherji M; Brill LM; Ficarro SB; Hampton GM; Schultz PG
    Biochemistry; 2006 Dec; 45(51):15529-40. PubMed ID: 17176074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a NPXY motif in growth factor receptor-bound protein 14 (Grb14) and its interaction with the phosphotyrosine-binding (PTB) domain of IRS-1.
    Rajala RV; Chan MD
    Biochemistry; 2005 Jun; 44(22):7929-35. PubMed ID: 15924411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide library screening for determination of SH2 or phosphotyrosine-binding domain sequences.
    Songyang Z; Liu D
    Methods Enzymol; 2001; 332():183-95. PubMed ID: 11305095
    [No Abstract]   [Full Text] [Related]  

  • 19. Alternative mode of binding to phosphotyrosyl peptides by Src homology-2 domains.
    Qin C; Wavreille AS; Pei D
    Biochemistry; 2005 Sep; 44(36):12196-202. PubMed ID: 16142918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solution structure of the human Grb14-SH2 domain and comparison with the structures of the human Grb7-SH2/erbB2 peptide complex and human Grb10-SH2 domain.
    Scharf PJ; Witney J; Daly R; Lyons BA
    Protein Sci; 2004 Sep; 13(9):2541-6. PubMed ID: 15322292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.